Article
TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
26 Jun 2023
Abstract excerpt
Immune checkpoint blockade (ICB) offers a new opportunity for treatment for gastric cancer (G.C.). Understanding the upstream regulation of immune checkpoints is crucial to further improve the efficacy of ICB therapy. Herein, using the CRISPR-Cas9-based genome-wide screening, we identified TRIM28 as one of the most significant regulators of PD-L1, a checkpoint protein, in G.C. cells. Mechanistically, TRIM28...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
